Purified vero rabies vaccine - serum free - VRVg-2 + Purified inactivated rabies vaccine - Verorab® + Purified inactivated rabies vaccine - Imovax® Rabies
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Rabies
Conditions
Rabies, Healthy Volunteers
Trial Timeline
Oct 21, 2019 → Apr 24, 2025
NCT ID
NCT04127786About Purified vero rabies vaccine - serum free - VRVg-2 + Purified inactivated rabies vaccine - Verorab® + Purified inactivated rabies vaccine - Imovax® Rabies
Purified vero rabies vaccine - serum free - VRVg-2 + Purified inactivated rabies vaccine - Verorab® + Purified inactivated rabies vaccine - Imovax® Rabies is a phase 3 stage product being developed by Sanofi for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT04127786. Target conditions include Rabies, Healthy Volunteers.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04127786 | Phase 3 | Completed |
Competing Products
20 competing products in Rabies